The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia
- 30 November 1994
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 18 (11), 805-810
- https://doi.org/10.1016/0145-2126(94)90159-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The clinical pharmacology of 6-mercaptopurineEuropean Journal of Clinical Pharmacology, 1992
- Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)International Journal of Cancer, 1992
- Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemiaThe Journal of Pediatrics, 1991
- In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral bloodBritish Journal of Cancer, 1991
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- Sensitivity to Purine Analogues in Childhood Leukemia Assessed by the Automated MTT-AssayPublished by Springer Nature ,1989
- Concurrent unilateral chromatid damage and DNA strand breakage in response to 6-thioguanine treatmentBiochemical Pharmacology, 1986
- Clinical utility of marrow cell tissue cultures in acute leukemia of childhoodAmerican Journal of Hematology, 1986
- Dissimilar actions of 6-mercaptopurine and 6-thioguanine in Chinese hamster ovary cellsBiochemical Pharmacology, 1985
- EFFECTS OF 6-MERCAPTOPURINE AND ANALOGS ON EXPERIMENTAL TUMORSAnnals of the New York Academy of Sciences, 1954